Insiders · CNSP

CNSP insider transactions

CNS Pharmaceuticals Inc. (CNSP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CNSP

• 52d
  SEC Form 4 filed by Chief Technology Officer Faulkner Eric

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 52d
  SEC Form 3 filed by new insider Faulkner Eric

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 52d
  SEC Form 4 filed by Chief Financial Officer O'Loughlin Steve

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 52d
  SEC Form 3 filed by new insider O'Loughlin Steve

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 113d
  SEC Form 4 filed by CEO and President Levin Rami

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 113d
  SEC Form 3 filed by new insider Levin Rami

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 157d
  SEC Form 4 filed by Director Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 157d
  SEC Form 4 filed by Chief Executive Officer Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 157d
  SEC Form 4 filed by Director Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 157d
  SEC Form 4 filed by Director Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 157d
  SEC Form 4 filed by Chief Financial Officer Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 157d
  SEC Form 4 filed by Director Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 157d
  SEC Form 4 filed by Director Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 627d
  SEC Form 4 filed by Large owner Cortice Biosciences, Inc.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 627d
  New insider Cortice Biosciences, Inc. claimed ownership of 573,368 shares (SEC Form 3)

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 745d
  SEC Form 4 filed by Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 745d
  SEC Form 4 filed by Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 745d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 745d
  SEC Form 4 filed by Evans Carl Anthony

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 745d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 745d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 745d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 745d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 809d
  SEC Form 4 filed by Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 809d
  Gumulka Jerzy bought $10,000 worth of shares (33,333 units at $0.30), increasing direct ownership by 345% to 43,006 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 809d
  Evans Carl Anthony bought $10,000 worth of shares (33,333 units at $0.30), increasing direct ownership by 26,666% to 33,458 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 809d
  Downs Christopher bought $20,000 worth of shares (66,666 units at $0.30), increasing direct ownership by 181% to 103,438 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 809d
  Climaco John M bought $50,000 worth of shares (166,666 units at $0.30), increasing direct ownership by 340% to 215,676 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 809d
  SEC Form 3 filed by new insider Mahery Amy

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 926d
  SEC Form 4 filed by Gumulka Jerzy (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 926d
  SEC Form 4 filed by Evans Carl Anthony (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 926d
  SEC Form 4 filed by Keyes Jeffry R. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 926d
  SEC Form 4 filed by Charles Faith L. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 926d
  SEC Form 4 filed by Cockroft Bettina M. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 926d
  SEC Form 4 filed by Andraczke Andrzej (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 943d
  SEC Form 4 filed by Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 943d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 943d
  SEC Form 4 filed by Evans Carl Anthony

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 943d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 943d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 943d
  SEC Form 4 filed by Andraczke Andrzej

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 977d
  SEC Form 4: Downs Christopher bought $34,177 worth of shares (27,000 units at $1.27), increasing direct ownership by 276% to 36,772 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 983d
  SEC Form 4: Climaco John M bought $4,944 worth of shares (2,750 units at $1.80), increasing direct ownership by 6% to 49,010 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 989d
  SEC Form 4 filed by Cockroft Bettina M. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 998d
  SEC Form 4: Priebe Waldemar sold $133,114 worth of shares (94,298 units at $1.41)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1082d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1082d
  SEC Form 3 filed by new insider Cockroft Bettina M.

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1090d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1090d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1101d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1104d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1105d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1107d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1121d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1121d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1207d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1207d
  SEC Form 3 filed by new insider Charles Faith L.

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1457d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1457d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1503d
  SEC Form 4: Downs Christopher was granted 33,000 shares, increasing direct ownership by 22% to 184,500 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)